🔍

SANGINITA - Sanginita Chemi.

📊 NSE: SANGINITA 🏢 Chemicals 📅 Last Updated: 12/14/2025 12:48

📢 Recent Corporate Announcements

Sanginita Chemicals Appoints Sangitaben D. Chavda as CFO Effective April 25, 2026

🟡 NEUTRAL ⭐ 5/10

MANAGEMENT 📅 25 Apr 2026, 06:37 PM

Sanginita Chemicals Limited has announced a transition in its financial leadership. Mr. Dipakkumar B. Chavda has resigned from the position of Chief Financial Officer effective April 25, 2026, citing personal reasons. To fill the vacancy, the company has appointed Ms. Sangitaben D. Chavda as the new CFO starting the same day. Ms. Sangitaben is a returning executive who previously served as the company's CFO for over eight years between 2017 and 2025.

Mr. Dipakkumar B. Chavda resigned as CFO effective April 25, 2026.
Ms. Sangitaben D. Chavda appointed as the new CFO effective April 25, 2026.
The new appointee previously held the CFO role from January 1, 2017, to August 1, 2025.
Ms. Sangitaben is the daughter of Directors Mr. Dineshsinh B. Chavada and Mrs. Hansaben D. Chavada.

💡 Investors should note that the appointment represents a return of a former officer and a family member to a key managerial position. No immediate impact on stock performance is expected, but investors should monitor future financial filings for consistency.

Sanginita Chemicals Appoints Sangitaben D. Chavda as CFO Effective April 25, 2026

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 25 Apr 2026, 06:37 PM

Sanginita Chemicals Limited has announced a transition in its top management with the resignation of Mr. Dipakkumar B. Chavda as Chief Financial Officer, effective April 25, 2026. To fill the vacancy, the company has appointed Ms. Sangitaben D. Chavda as the new CFO starting the same date. Ms. Sangitaben is a returning executive, having previously served as the company's CFO for over eight years between 2017 and 2025. She is also the daughter of two current directors, maintaining the family-led management structure.

Mr. Dipakkumar B. Chavda resigned as CFO effective April 25, 2026, citing personal reasons.
Ms. Sangitaben D. Chavda appointed as the new CFO effective April 25, 2026.
The new CFO previously held the same position at the company from January 1, 2017, to August 1, 2025.
Ms. Sangitaben is the daughter of Directors Mr. Dineshsinh B. Chavada and Mrs. Hansaben D. Chavada.

💡 As the new CFO has extensive prior experience with the company, investors should expect continuity in financial operations, though they should monitor for any changes in financial reporting quality.

Sanginita Chemicals CFO Dipakkumar B. Chavda Resigns; Board Meeting Set for April 25

🔵 WATCH ⭐ 6/10

MANAGEMENT 📅 13 Apr 2026, 05:58 PM

Sanginita Chemicals Limited informed the exchange on April 13, 2026, that Chief Financial Officer Mr. Dipakkumar B. Chavda has resigned citing personal reasons. The resignation letter will be presented to the Board of Directors during their scheduled meeting on April 25, 2026. The company is actively seeking a suitable replacement to ensure a smooth transition in financial management. Investors should await further updates regarding the official resignation date and the appointment of a successor following the board meeting.

Resignation letter received from CFO Dipakkumar B. Chavda on April 13, 2026
Resignation cited as being due to personal reasons
Board meeting scheduled for April 25, 2026, to address the leadership change
Company is currently searching for a suitable candidate to fill the CFO position

💡 Investors should watch for the announcement of the new CFO to ensure financial stability and continuity. No immediate action is required until the successor's profile is disclosed.

Sanginita Chemicals Shareholders Approve Preferential Share Issue and Capital Increase

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 11 Apr 2026, 08:22 PM

Sanginita Chemicals Limited successfully passed five key resolutions during its Extraordinary General Meeting held on April 11, 2026. Shareholders approved the issuance of equity shares on a preferential basis for both cash and share swap considerations, providing a path for capital infusion and potential acquisitions. Additionally, the company received authorization to increase its authorized share capital and expand its borrowing and investment limits. All resolutions were passed with the requisite majority, signaling strong shareholder support for the company's growth strategy.

Approved preferential issuance of equity shares for both cash and share swap transactions.
Authorized an increase in the company's Share Capital and amendment of the Memorandum of Association.
Increased borrowing powers under Section 180(1)(c) and investment limits under Section 186.
All 5 resolutions were passed with the requisite majority during the EGM attended by 31 members via video conferencing.

💡 Investors should monitor the specific pricing and allotment details of the preferential issue to assess potential dilution and the strategic value of the share swap. The expansion of borrowing and investment limits suggests the company is preparing for significant capital expenditure or strategic expansion.

Sanginita Chemicals Approves Preferential Share Issue and Increased Borrowing Limits

🟢 POSITIVE ⭐ 7/10

FUNDRAISE 📅 11 Apr 2026, 05:51 PM

Sanginita Chemicals Limited held an Extra Ordinary General Meeting (EGM) on April 11, 2026, where shareholders approved several critical financial resolutions. Key approvals include the issuance of equity shares on a preferential basis for both cash and consideration other than cash. Furthermore, the company received the mandate to increase its authorized share capital, borrowing powers under Section 180(1)(c), and investment/loan limits under Section 186. These steps indicate a significant move towards capital infusion and potential expansion or acquisition activities.

Approval for issuance of equity shares on a preferential basis for both cash and non-cash consideration.
Shareholders approved an increase in the company's Authorized Share Capital.
Board granted authority to increase borrowing limits under Section 180(1)(c) of the Companies Act.
Increased threshold for loans, guarantees, and investments under Section 186 approved by requisite majority.
The EGM was conducted via Video Conferencing (VC) / Other Audio Visual Means (OAVM) on April 11, 2026.

💡 Investors should watch for subsequent filings regarding the specific pricing and quantity of shares to be issued in the preferential allotment. The expansion of borrowing and investment limits suggests the company is preparing for significant capital expenditure or strategic investments.

Sanginita Chemicals Promoters Confirm No New Share Pledging in Annual SEBI Disclosure

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Apr 2026, 02:15 PM

Promoters of Sanginita Chemicals, including Dineshsinh B. Chavada and Vijaysinh D. Chavda, have filed their annual declaration under SEBI (SAST) Regulations. The declaration confirms that the promoter group and persons acting in concert (PAC) have not created any new encumbrances on their shares during the financial year. This routine disclosure is mandatory for all listed companies to maintain transparency regarding promoter holdings. It ensures that there are no hidden pledges that could impact the stock's stability or signal financial distress.

Declaration filed under Regulation 31(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
Promoters including Sanginita Industries LLP confirmed zero new direct or indirect encumbrances for the period.
The filing was submitted to the National Stock Exchange (NSE) and the company's Audit Committee as per regulatory timelines.

💡 This is a routine regulatory filing with no impact on business fundamentals. Investors should view this as a standard compliance update confirming the status of promoter holdings.

Sanginita Chemicals: Trading Window Closure for FY26 Year-End Results Starting April 1

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 31 Mar 2026, 04:34 PM

Sanginita Chemicals Limited has announced the closure of its trading window effective April 1, 2026, in preparation for the financial results for the quarter and year ending March 31, 2026. This action is a standard regulatory requirement under the SEBI (Prohibition of Insider Trading) Regulations, 2015. The window will remain closed for all designated persons and their immediate relatives until 48 hours after the financial results are declared. This is a routine administrative filing and does not indicate any change in the company's operational status.

Trading window closure effective from April 1, 2026
Pertains to the financial results for the quarter and year ending March 31, 2026
Window to reopen 48 hours after the official declaration of financial results
Complies with SEBI (Prohibition of Insider Trading) Regulations, 2015

💡 No action is required as this is a routine regulatory compliance filing. Investors should look forward to the actual financial results for performance assessment.

Sanginita Chemicals Announces Open Offer for 26% Stake at ₹1.55 Per Share

🟡 NEUTRAL ⭐ 8/10

M&A 📅 30 Mar 2026, 04:17 PM

Sanginita Chemicals has released a Detailed Public Statement regarding a mandatory open offer to acquire up to 4,50,20,200 equity shares, representing 26% of the expanded voting share capital. The offer is priced at ₹1.55 per share, involving a total consideration of approximately ₹6.98 crore. This offer is triggered under SEBI (SAST) Regulations following a Share Purchase Agreement (SPA) by the acquirers. Finshore Management Services Ltd is acting as the manager to the offer.

Open offer for 4,50,20,200 equity shares representing 26% of expanded voting capital.
Offer price fixed at ₹1.55 per equity share to be paid in cash.
Total maximum consideration for the offer is valued at ₹6,97,81,310.
The offer is managed by Finshore Management Services Ltd under SEBI (SAST) Regulations.
Expanded share capital of the company stands at 17,31,54,615 equity shares.

💡 Investors should compare the current market price of Sanginita Chemicals with the offer price of ₹1.55; tendering shares is only logical if the market price is lower than the offer price.

Sanginita Chemicals Reports Cyber Security Incident; Website Restoration Expected in 48 Hours

🔵 WATCH ⭐ 4/10

REGULATORY 📅 25 Mar 2026, 07:57 PM

Sanginita Chemicals Limited has reported a cyber security incident discovered on March 25, 2025, involving its official website. The company disclosed that the website was hacked, resulting in certain disseminated information becoming inaccessible to the public. Importantly, management has clarified that the breach has not impacted the company's core operational or financial systems. Efforts to regain control are underway, with full website functionality expected to be restored within 48 hours.

Cyber security incident detected on March 25, 2025, specifically targeting the corporate website.
Management confirms that core business operations and internal systems remain unaffected.
Access to the website and its information is expected to be restored within a 48-hour timeframe.
The company is currently analyzing the incident to prevent future occurrences.

💡 Investors should monitor for any further updates regarding potential data leaks, though the immediate impact on business fundamentals appears negligible. No immediate portfolio changes are recommended based on this specific incident.

Sanginita Chemicals to Acquire Agastya Green Energy via ₹19.95 Cr Share Swap

🟢 POSITIVE ⭐ 8/10

M&A 📅 25 Mar 2026, 05:34 PM

Sanginita Chemicals has scheduled an EGM on April 11, 2026, to seek shareholder approval for the 100% acquisition of Agastya Green Energy Limited (AGEL). The acquisition will be executed via a share swap, issuing 1,52,87,356 equity shares at ₹13.05 per share to BNG Investment LLC. To accommodate this and future growth, the company is proposing to increase its authorized share capital from ₹27 crore to ₹77 crore and raise its investment/loan limits to ₹100 crore.

Acquisition of 100% stake in Agastya Green Energy Limited through a preferential share swap
Issuance of 1,52,87,356 equity shares at a fixed price of ₹13.05 per share
Proposed increase in Authorised Share Capital from ₹27 crore to ₹77 crore
Expansion of Section 186 limits for loans, guarantees, and investments up to ₹100 crore
Relevant date for pricing the preferential issue set as March 12, 2026

💡 Investors should evaluate the strategic fit of Agastya Green Energy into Sanginita's portfolio and monitor the resulting equity dilution from the 1.53 crore new shares. The move signals a significant pivot or expansion into the green energy sector which may impact long-term valuation.

Sanginita Chemicals to Acquire Agastya Green Energy; New Promoters to Take Control via Share Swap

🔵 WATCH ⭐ 10/10

M&A 📅 20 Mar 2026, 07:40 PM

Sanginita Chemicals has entered into a Share Swap and Purchase Agreement to acquire 100% of Agastya Green Energy Limited (AGEL) by issuing 1.53 crore fresh shares. The new acquirer, B N G Investment LLC, will also infuse cash by subscribing to 1.92 crore shares at ₹13.05 per share. The current promoter group is exiting their entire 65.79 lakh share stake, leading to a change in control and a mandatory open offer. This move shifts the company's focus from chemicals to the renewable energy and solar manufacturing sector.

Issuance of 1.52 crore shares to acquire 95 lakh shares of AGEL, a solar energy startup.
Preferential cash infusion through the allotment of 1.91 crore shares at ₹13.05 per share.
Complete exit of existing promoters (65.79 lakh shares) and entry of new promoters B N G Investment LLC and Anubhav Agarwal.
Mandatory open offer triggered under SEBI SAST Regulations due to the change in management and control.
Strategic pivot to solar panel manufacturing and EPC, despite the target entity having nil turnover as of Nov 2025.

💡 This is a total transformation of the company's business model and leadership; investors should evaluate the new promoters' track record and wait for open offer details. The transition from a chemical manufacturer to a pre-revenue solar player carries high execution risk.

Sanginita Chemicals to Hold EGM for Preferential Share Issue and Higher Borrowing Limits

🔵 WATCH ⭐ 7/10

FUNDRAISE 📅 20 Mar 2026, 07:33 PM

Sanginita Chemicals has scheduled an Extraordinary General Meeting (EGM) on April 11, 2026, to seek shareholder approval for a preferential issue of equity shares for both cash and non-cash consideration. The company also proposes to increase its authorized share capital and significantly expand its borrowing powers under Section 180(1)(c). Additionally, resolutions are being moved to increase the limits for loans, guarantees, and investments under Section 186 of the Companies Act, 2013. These steps collectively suggest a major capital restructuring or preparation for significant expansion.

EGM scheduled for April 11, 2026, to approve preferential equity issuance for cash and non-cash consideration.
Proposal to increase the Company's authorized share capital and overall borrowing powers of the Board.
Seeking higher thresholds for inter-corporate loans, guarantees, and investments under Section 186.
Remote e-voting facility to be available from April 8 (11:00 AM) to April 10 (5:00 PM), 2026.
Cut-off date for determining member voting eligibility is set for April 4, 2026.

💡 Investors should monitor the specific pricing and allotment details of the preferential issue to assess potential equity dilution. The request for increased borrowing and investment limits suggests a shift toward more aggressive growth or capital expenditure that warrants close observation of the debt-to-equity ratio.

B N G Investment LLC to Acquire Control of Sanginita Chemicals; Open Offer at ₹13.55/Share

🟢 POSITIVE ⭐ 10/10

M&A 📅 20 Mar 2026, 07:30 PM

B N G Investment LLC and Mr. Anubhav Agarwal are set to acquire a controlling stake in Sanginita Chemicals through a combination of share purchases from existing promoters and a massive preferential allotment. The transaction involves a share swap to acquire Agastya Green Energy Limited (AGEL), making it a subsidiary, and a cash-based preferential issue at ₹13.05 per share. Consequently, the acquirers have triggered a mandatory open offer to public shareholders for a 26% stake at ₹13.55 per share. This deal marks a complete exit for the current promoter group and a significant shift in the company's business direction.

Open offer launched for 1,56,89,957 shares (26% stake) at ₹13.55 per share, totaling ₹21.26 crore.
Preferential allotment of 3,44,44,436 shares to B N G Investment LLC via cash and share swap.
Sanginita Chemicals to acquire 100% of Agastya Green Energy Limited (AGEL) through the share swap arrangement.
Existing promoters (Chavada family and LLP) to sell their entire 25.40% stake to the new acquirers.
The emerging fully diluted voting capital will expand significantly to 6,03,45,986 equity shares.

💡 Investors should monitor the market price relative to the open offer price of ₹13.55; if the market price remains lower, tendering in the offer may be beneficial. Long-term investors should evaluate the growth potential of the newly acquired green energy business under the new management.

Sanginita Chemicals to Acquire Agastya Green Energy; New Promoters to Take Control

🟢 POSITIVE ⭐ 10/10

M&A 📅 20 Mar 2026, 07:26 PM

Sanginita Chemicals is undergoing a complete management and business transformation by acquiring Agastya Green Energy Limited (AGEL) via a share swap of 1.52 crore shares. The company will also raise fresh capital by issuing 1.91 crore shares at ₹13.05 each to B N G Investment LLC. Current promoters are exiting their entire 65.78 lakh share stake, handing over control to new acquirers who plan to pivot the business from chemicals into solar manufacturing and renewable energy. This transaction triggers a mandatory open offer for minority shareholders under SEBI regulations.

Issuance of 1,52,87,356 equity shares to acquire 95,00,000 shares of Agastya Green Energy via share swap.
Preferential allotment of 1,91,57,080 shares for cash infusion at a price of ₹13.05 per share.
Existing promoters to exit completely by selling their entire holding of 65,78,994 shares to the new acquirers.
Strategic diversification into solar panel manufacturing, EPC, and power generation units.
Mandatory open offer triggered for public shareholders due to the change in control and ownership.

💡 Investors should closely monitor the open offer price and the execution roadmap of the new management in the high-growth renewable energy sector. The significant capital infusion and business pivot could lead to a long-term re-rating of the company.

Sanginita Chemicals Board to Meet on March 20 for Preferential Issue; Trading Window Closed

🔵 WATCH ⭐ 6/10

FUNDRAISE 📅 17 Mar 2026, 04:57 PM

Sanginita Chemicals Limited has announced a board meeting scheduled for March 20, 2026, to consider a proposal for raising funds through a preferential issue of equity shares. In accordance with SEBI regulations, the trading window for dealing in the company's shares has been closed effective March 17, 2026. The window will remain closed until 48 hours after the outcome of the board meeting is publicly disclosed. This move indicates a strategic intent to infuse capital, which will be subject to shareholder and regulatory approvals.

Board meeting scheduled for March 20, 2026, to approve a preferential issue of equity shares.
Trading window for insiders closed from March 17, 2026, to prevent insider trading ahead of the news.
Trading restriction to be lifted 48 hours after the board meeting outcome is announced.
The proposed fundraise is subject to statutory, regulatory, and shareholder approvals.

💡 Investors should wait for the March 20 board meeting outcome to understand the scale of the fundraise and the identity of the participating investors. Monitor the issue price and potential equity dilution versus the growth prospects the new capital might provide.

View All SANGINITA Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

The company operates in a single segment, Chemicals, which saw revenue grow by 51.6% YoY to INR 229.68 Cr in FY25 from INR 151.50 Cr in FY24. However, H1FY26 revenue showed signs of volatility with a reported loss of INR 0.59 Cr at the PBT level.

Geographic Revenue Split

Not disclosed in available documents, though operations are concentrated at the manufacturing facility in Chhatral, Gujarat.

Profitability Margins

Profitability is thin and declining; PBT margin compressed from 0.69% in FY24 to 0.36% in FY25. Net Profit (PAT) for FY25 was INR 0.62 Cr, a decline of 19.6% from INR 0.77 Cr in FY24, primarily due to high raw material costs and increased depreciation.

EBITDA Margin

PBILDT margin was reported at 2.32% in FY23 (INR 3.45 Cr). CARE Ratings noted that margins remain thin due to susceptibility to volatile raw material prices, with a target of >5% required for a positive rating action.

Capital Expenditure

Property, Plant and Equipment (PPE) stood at INR 13.93 Cr as of September 30, 2025, down from INR 14.74 Cr in March 2025. Depreciation expense increased 125% YoY to INR 1.68 Cr in FY25, suggesting recent prior commissioning of assets.

Credit Rating & Borrowing

The credit rating was downgraded to CARE BB+; Stable / CARE A4+ in April 2023 from CARE BBB-; Negative. The ratings were subsequently withdrawn in January 2024 at the company's request. Borrowing costs are high, with finance costs of INR 2.44 Cr in FY25 representing 1.06% of total revenue.

⚙️ Operational Drivers

Raw Materials

Copper is the primary raw material, used to produce copper-based inorganic chemicals. Raw material costs (consumption plus stock-in-trade purchases) totaled INR 220.88 Cr in FY25, representing approximately 96.1% of total revenue.

Import Sources

Not specifically disclosed, though the company generally procures copper on a spot or advance payment basis to avail cash discounts.

Capacity Expansion

Current installed capacity is 12,200 MTPA for manufacturing metal-based inorganic chemicals as of March 31, 2023. No specific future expansion timeline was provided in the documents.

Raw Material Costs

Raw material costs surged by 53.4% YoY to INR 220.88 Cr in FY25. The company uses a procurement strategy of spot/advance payments to manage costs, but remains highly vulnerable to global copper price volatility.

Manufacturing Efficiency

Capacity utilization has seen a continuous decline over the four years ending FY23 due to lower demand from key clients and international markets.

📈 Strategic Growth

Expected Growth Rate

15-20%

Growth Strategy

Growth is targeted through volume-driven expansion in the scale of operations, aiming for a Total Operating Income (TOI) exceeding INR 200-250 Cr. The strategy involves leveraging the 12,200 MTPA capacity and established relationships in the metal-based inorganic chemical industry to increase market share in copper sulphate and chloride products.

Products & Services

Metal-based inorganic chemical intermediates including Cuprous Chloride, Cupric Chloride, Copper Sulphate, and CPC Blue Crude.

Brand Portfolio

SANGINITA

Market Expansion

The company is focusing on increasing its international demand presence, which had previously seen a dip impacting capacity utilization.

Strategic Alliances

The company does not have any Subsidiary, Associate, or Joint Venture companies.

🌍 External Factors

Industry Trends

The metal-based inorganic chemical industry is characterized by high raw material price sensitivity and strict environmental regulations. The industry is evolving toward higher compliance standards, requiring companies to invest in pollution control.

Competitive Landscape

The company faces competition from other inorganic chemical manufacturers, particularly those with better backward integration or larger scales of operation.

Competitive Moat

The moat is based on the 30+ years of experience of promoters Mr. Dinesh B. Chavada and Mr. Vijaysinh Chavada in the chemical industry and established business relations with a reputed client base. This is moderately sustainable but challenged by low entry barriers in basic chemical manufacturing.

Macro Economic Sensitivity

Highly sensitive to global commodity prices (Copper) and industrial demand cycles in the chemical sector.

Consumer Behavior

Shift toward suppliers with consistent quality and strict environmental compliance (pollution norms).

Geopolitical Risks

International demand fluctuations have historically impacted sales volumes and capacity utilization.

⚖️ Regulatory & Governance

Industry Regulations

Operations are governed by the Companies Act 2013 and environmental standards for chemical manufacturing. The company maintains regular physical verification of PPE every three years to comply with audit requirements.

Environmental Compliance

The company must strictly adhere to pollution control and environmental compliance norms as per Gujarat government regulations; failure to comply poses a significant risk to operational continuity.

Taxation Policy Impact

Effective tax rate for FY25 was approximately 25.4% (INR 21.03 Lakhs tax on INR 82.88 Lakhs PBT).

Legal Contingencies

No specific pending court cases or values were disclosed in the provided documents.

⚠️ Risk Analysis

Key Uncertainties

Volatility in copper prices (high impact), potential for unauthorized override of internal controls (inherent risk), and high working capital intensity (liquidity risk).

Geographic Concentration Risk

Manufacturing is 100% concentrated in Gandhinagar, Gujarat, making it susceptible to regional regulatory or environmental policy changes.

Third Party Dependencies

High dependency on copper suppliers; cash flow from operations was previously negative (INR -3.21 Cr) due to increased advances given to suppliers.

Technology Obsolescence Risk

The company uses standard chemical manufacturing processes; no significant digital transformation or high-tech risks were noted.

Credit & Counterparty Risk

Trade receivables stood at INR 32.72 Cr as of Sept 2025, representing roughly 14% of annual revenue, indicating significant credit exposure to customers.